$500M Convertible Notes Offering Announced, With 2027 Note Repurchase
GH has more than doubled off its 52-week low of $74.55.
Summary
Guardant is selling $500.0 million of convertible senior notes due 2032 in a Rule 144A private placement, with an option for up to $50.0 million more. Terms — coupon, conversion rate — aren't set yet; they price at market. Part of the proceeds goes to repurchase a slice of its 0% convertible notes due 2027, and part funds capped call transactions meant to blunt dilution from conversion. The rest is for general corporate purposes, including possible acquisitions, though the company says it has no agreements in place. Convertible issuance typically pressures the stock on announcement given dilution and hedge-related selling, and this comes right after Q3 revenue of $361.0 million, up 36%, with the net loss widening to $124.4 million. Pricing terms will determine how much real dilution lands.
At the time of this announcement, GH was trading at $154.78 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $20.9B. The 52-week trading range was $74.55 to $191.05. This news item was assessed with negative market sentiment and an importance score of 7 out of 10. Source: BusinessWire.